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Running title: Tolerance induction to GRP allografts
Abbreviated summary
White matter repair through allotransplantation of glial progenitors is now feasible in immune-
deficient animals. However, immunological barrier precludes its clinical translation. We describe 
a strategy based on costimulation blockade inducing immunological hyporesponsiveness and 
supporting long-term functionality of allotransplanted myelinating oligodendrocytes.
Abstract
The immunological barrier currently precludes the clinical utilization of allogeneic stem cells. 
Although glial-restricted progenitors have become attractive candidates to treat a wide variety of 
neurological diseases, their survival in immunocompetent recipients is limited. In this study, we 
adopted a short-term, systemically applicable costimulation blockade-based strategy using 
CTLA4-Ig and anti-CD154 antibodies to modulate T cell activation in the context of allogeneic 
glial-restricted progenitor transplantation. We found that costimulation blockade successfully 
prevented rejection of allogeneic glial-restricted progenitors from immunocompetent mouse brains. 
The long-term engrafted glial-restricted progenitors myelinated dysmyelinated adult mouse brains 
within one month. Furthermore, we identified a set of plasma miRNAs whose levels specifically 
correlated to the dynamic changes of immunoreactivity and as such could serve as biomarkers for 
graft rejection or tolerance. We put forward a successful strategy to induce alloantigen-specific 
hyporesponsiveness towards stem cells in the central nervous system, which will foster effective 
therapeutic application of allogeneic stem cells.
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Introduction
Neurological disorders are the most compelling targets of cell-based therapy due to the very limited 
capacity of the central nervous system (CNS) to undergo spontaneous regeneration. This 
particularly accounts for glial diseases, as the initially preserved neuronal cytoarchitecture is 
believed to foster white matter repair (Boltze et al., 2017). A broad variety of stem cell populations 
being capable of differentiating into oligodendrocytes including neural and oligodendrocyte 
progenitor cells, as well as glial-restricted progenitors (GRPs) have been investigated (Goldman, 
2016). Moreover, oligodendrocytes directly derived from induced pluripotent stem cells, were 
shown to rapidly myelinate the newborn and adult CNS (Ehrlich et al., 2017). 
GRPs arise from neural stem cells and can differentiate into both oligodendrocytes and astrocytes 
under appropriate conditions (Rao and Mayer-Proschel, 1997; Rao et al., 1998). Apart from 
leukodystrophies or multiple sclerosis, GRPs become promising candidates to treat a wide variety 
of neurological diseases (Goldman et al., 2012; Goldman, 2016). Human GRPs (hGRPs) were 
shown to extensively migrate and myelinate the congenitally dysmyelinated newborn mouse brains 
and prolong the lifespan of the animals (Windrem et al., 2004; Windrem et al., 2008; Wang et al., 
2013; Lyczek et al., 2017). These cells also preserve electrophysiological function in focal 
inflammatory spinal cord demyelination (Walczak et al., 2011), support regeneration after spinal 
cord injury (Haas and Fischer, 2013), replenish depleted precursor pools, generate new myelin, and 
reverse radiation-induced behavioral defects in adult rats (Piao et al., 2015).
Since cell treatments in future clinical scenarios will require very well-defined, thoroughly 
characterized, and standardized cell populations, the use of allogeneic grafts is believed to be the 
most likely approach. This is also advantageous when treating inherited diseases and acute injury 
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for which autologous cell generation and differentiation paradigms are not suitable. However, to 
date, the immunological barrier represents an unsurmountable challenge to widespread clinical 
application of allogeneic cells. In case of GRPs, robust rejection in less than three weeks after 
transplantation into white matter of immunocompetent adult recipients (Janowski et al., 2014; 
Srivastava et al., 2016) strongly limits GRP migration potential and therapeutic effects, so far 
demanding conventional immunosuppression regimens. Besides their low efficacy, risk of 
infection and tumor formation, immunosuppression-inherent effects, as well as associated cellular 
and systemic toxicities complicate preclinical studies and preclude successful clinical translation 
(Diehl et al., 2017) of GRP-based treatments. Thus, novel immunomodulatory strategies are 
imperative.
Since T cells play a central role in the immune response toward allografts, an emerging 
immunomodulatory strategy targets costimulatory molecules involved in T cell activation 
(Verbinnen et al., 2010; Kinnear et al., 2013; Marino et al., 2016). One of the most important 
costimulatory interactions are that of CD80/CD86 found on antigen presenting cells (APCs) 
interacting with CD28 located on T cells, and CD40 on APCs engaging CD154 on T cells (Lafferty 
et al., 1983). CTLA4-Ig blocks the CD80/CD86-CD28 interaction. It prevents complete T cell 
activation with consecutive T cell anergy, thus protecting allografts in various small and large 
animal solid organ (Shiraishi et al., 2002; Graves et al., 2009) and cell transplantation models 
(Lenschow et al., 1992). The concept has been successfully introduced into the clinic (Masson et 
al., 2014). In addition, despite some initial setbacks, preclinical studies have demonstrated the 
potency of anti-CD154 antibody (MR-1) treatment targeting the CD40-CD154 axis for allograft 
rejection prevention (Webber and Vincenti, 2016). The combination of CTLA4-Ig and MR-1 has 
also been shown to induce long-term survival of skin and cardiac allografts (Larsen et al., 1996) as 
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well as human embryonic stem cell-derived pancreatic endoderm xenografts in rodents (Szot et al., 
2015). However, it remains largely unknown whether the blood brain barrier (BBB) and microglial 
response may limit systemic costimulation blockade-based tolerance induction for allogeneic 
GRPs using CTLA4-Ig and MR-1. 
One of the key obstacles in clinical translation of cell therapies is the lack of biomarkers that could 
indicate the status of transplanted cells (Bohmig et al., 2010). Cellular imaging offers limited 
sensitivity and specificity (Berman et al., 2011), so there is growing interest in exploiting  
miRNAs, lipids or proteins as blood biomarkers for intracerebral graft surveillance (Hamdorf et 
al., 2017). MiRNAs are small, non-coding RNAs that act as key regulators of B- and T-cell 
differentiation, maturation, and proliferation. They also play a role in regulatory T cell (Treg) 
function and antigen signaling (Hoefig and Heissmeyer, 2008; Gaudet et al., 2017). Their 
sensitivity, conserved expression and relative tissue specificity have triggered their potential utility 
as biomarkers for neuroinflammation (Hoefig and Heissmeyer, 2008; Gaudet et al., 2017; Sajja et 
al., 2017). 
In the present study, we transplanted fully histocompatibility complex-mismatched GRP allografts 
into the mouse brain parenchyma and studied allograft survival and function by non-invasive 
imaging techniques and histological investigation. We showed that short-term costimulation 
blockade induced indefinite engraftment of GRP allografts in the mouse CNS. Moreover, several 
classes of circulating miRNAs were identified to be sensitive biomarkers for graft 
rejection/acceptance.
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Materials and methods
Mice
Five/one cohorts of immunocompetent C57BL/6 albino (B6, male, 8-week-old, Jackson 
Laboratory) mice were used for allogeneic/xenogeneic GRP survival studies. Two cohorts of 
genetically dysmyelinated shiverer (male, 6-week-old, Jackson Laboratory) mice were included to 
examine the myelination capacity of allogeneic mouse GRPs (mGRPs) in adult brains treated with 
costimulation blockade (CoB). Immunodeficient, graft-accepting mice served as controls for cell 
or transplantation-related failures (scid mice control for B6 mice, and shiverer-rag2 mice control 
for shiverer mice). Every cohort of animals contained three groups: immunocompetent 
animals+CoB group, immunocompetent animals+phosphate buffer saline (PBS, control group), 
and immunodeficient animals (n=5/group). Detailed animal assignment, measurements, and 
dropouts are listed in Table 1. Drop-outs were not replaced. All mice were micro-chipped, 
randomly assigned into different groups, as well as manipulated and analyzed in a blinded manner. 
Animals were housed under an artificial light-dark (12 h/12 h) cycle and had access to food and 
water ad libitum. 
Isolation and characterization of GRPs
Allogeneic GRPs were isolated from the spinal cord of a proteolipid protein (PLP)-green 
fluorescent protein (GFP) (for detection of differentiated oligodendrocytes)/β-actin-luciferase (for 
detection of engrafted cells via bioluminescent imaging) transgenic mouse strain at embryonic day 
13.5 as described (Phillips et al., 2012). Cells were maintained in serum-free Dulbecco’s modified 
Eagle’s medium (DMEM)/F12 (Life Technologies) supplemented with N2 (Life Technologies), 
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B27 (Life Technologies), bovine serum albumin (Sigma-Aldrich), heparin (Sigma-Aldrich), and 
basic fibroblast growth factor (bFGF, PeproTech) (Lepore et al., 2006). 
Primary hGRPs were derived from midgestation fetuses and thoroughly characterized as described 
elsewhere (Sandrock et al., 2010) (Q Therapeutics). Cells were immortalized using lentivirus 
encoding the SV40 large T-antigen, and were selected with puromycin. They were maintained in 
serum-free DMEM/F12 medium supplemented with N2, B27, bovine serum albumin, and bFGF 
(Janowski et al., 2013). Without hGRP indication, transplantations were performed with mGRPs.
Allogeneic mGRPs were characterized immunocytochemically. Briefly, cells were fixed in 4% 
paraformaldehyde for 20 min, blocked by 10% donkey serum in 0.1% Triton X-100-PBS for 2 h 
at room temperature. Cells were incubated with appropriate dilutions of primary antibodies in 
blocking solution overnight at 4°C, rinsed with PBS, and incubated with corresponding secondary 
antibodies (Alexa Fluro-594, Life Technologies-A11058) in blocking buffer for 1 h at room 
temperature. The culture was rinsed three times with PBS, counterstained with 4', 6-diamidino-2-
phenylindole (DAPI, Sigma-Aldrich-D9542, 5 µg/ml), and imaged using a Zeiss AX10 
fluorescence microscope. Primary antibodies were: anti-PDGFRα (1:1000, Abcam-ab61219), anti-
A2B5 (1:500, Life Technologies-433110), anti-Olig1 (1:500, Millipore-AB15620), anti-Olig2 
(1:500, Millipore-AB9610), anti-NG2 (1:500, Millipore-AB5320), anti-MBP (1:1000, AbD 
Serotec-MCA409S), anti-GFAP (1:1000, DAKO-Z0334), anti-Iba1 (1:500, Wako-SAN3725), 
anti-CD11b (1:500, BioLegend-101202), anti-βIII-Tubulin (1:500, Covance-PRB-435P), anti-
Nestin (1:500, Millipore-MAB535), anti-CXCR4 (1:300, Abcam-ab1670), and anti-FGFR1 
(1:200, Cell Signaling Technology-9740).
Cell transplantation
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Anesthesia was induced with 5% isoflurane and maintained with 2% isoflurane in room air and 
oxygen mixed at 3:1 ratio. Mice were shaved and stabilized in a Cunningham adaptor mounted on 
a stereotactic frame (both Stoelting). A 7.0-mm skin incision was made along the midline of the 
skull. The skull bone was carefully exposed and Bregma was identified. A burr hole was placed 
according to the targets (B6 and scid mice: AP=1.7 mm; ML=0.7 mm; DV=2.0 mm). Cells were 
loaded into a 10-μl gastight Hamilton syringe (#1701) with an attached 31-gauge needle (Hamilton) 
and lowered into the brain according to the coordinates. Four microliters of mGRP suspension 
(100,000 cells/μl in PBS) were injected at a rate of 1 μl/min using a nano-injector (Stoelting). The 
needle was kept in place for 2 min after injection to minimize backflow and was then withdrawn 
slowly. The syringe was removed and the wound was closed with sutures (Silk 3.0; Ethicon). 
Shiverer and shiverer-rag2 mice received three injections targeting the corpus callosum to 
investigate the myelination capacity with 3 μl of mGRPs each through one hole (AP=0 mm; 
ML=2.1 mm). The first injection was placed vertically with a 2.0-mm depth. The second injection 
had a 30° angle with the vertical line to the rostral. The third injection had a 45° angle with the 
vertical line to the caudal.
Costimulation blockade
CTLA4-Ig (ORENCIA, Bristol-Myers Squibb Company) was intraperitoneally administered at 
500 μg/mouse in combination with 500 μg/mouse anti-CD154 mAbs (MR-1, BioXCell) at the time 
of transplantation and on post operation day (POD)2, 4, and 6, based on previous tolerance 
induction protocol in rodents (Larsen et al., 1996; Szot et al., 2015). Booster CoB mice received 
additional 500 μg/mouse CTLA4-Ig on POD30, 60, and 90.
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Bioluminescent imaging (BLI) of transplanted GRPs in vivo
Bioluminescence images were acquired using an IVIS Spectrum/CT instrument. Animals were 
anesthetized by 2% isoflurane gas in oxygen, with 150 mg/kg D-luciferin (Gold Biotechnology) 
injected intraperitoneally. BLI was initiated the day after cell transplantation and continued on 
POD3, 7, 10, and then weekly until the endpoints. Images were quantified by drawing regions of 
interest (ROIs) over the mouse brains or backs, with data expressed as total photon flux (photons/s). 
Cell survival curves were generated as logistic graphs. A drop in BLI signal to the background 
level (signal generated by other parts of the body) was interpreted as rejection of transplanted cells 
(Janowski et al., 2014; Srivastava et al., 2016).
Adoptive transfer experiment
For adoptive transfers, single-cell suspensions were prepared from the spleen of B6 mice (one pair 
of 154-day post intracerebral mGRP transplanted CoB and control B6 mice, one age-matched naïve 
mouse). Two million purified T cells were injected into the retro-orbital blood sinus of scid mice 
(5 groups, n=4/group). Four days later, one million mGRPs were subcutaneously transplanted into 
the back of each scid mouse and the survival of allografts was monitored by BLI. 
Mixed lymphocyte reaction (MLR)
T cell isolation was performed via negative selection for B cells, NK cells, 
monocytes/macrophages, dendritic cells, erythrocytes, and granulocytes from splenocytes of 
recipient mice using magnetic bead sorting. Briefly, splenocytes were incubated with purified rat 
anti-mouse B220, Gr-1, TER-119, I-A/I-E, CD11b, and CD16/32 (eBioscience) and subsequently 
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incubated with anti-rat IgG Dynabeads (Dynabeads® Untouched™ Mouse T Cells, Life 
technologies) leading to a T cell enriched population following magnetic selection. Two micromole 
of CFSE (Vybrant CFSE SE cell tracer kit, Life technologies) was applied for tracking 
proliferation.
Dendritic cells (DC) were generated from both donor matched (FVBN) and third party derived 
(Balb/c) bone marrow after cultured for 7 days with IL-4 and GM-CSF in a 37°C incubator. DCs 
were activated with a 1:5000 diluted lipopolysaccharides 24 h prior to MLR plating. CD11c-
positive DCs were then isolated using positive magnetic sorting according to the manufacturer’s 
protocol (Mouse CD11c Positive Selection Kit, STEMCELL Technologies). 
CFSE-labeled T cells and DCs were cultured together with either intact mGRPs or ultrasonicly 
minced mGRPs for 4 d in 37°C, collected, and stained with Fixable Viability Dye (eBioscience) 
according to the manufacturer’s protocol. Samples were stained for CD4 and CD8 and acquired on 
a LSRII flow cytometry (BD Biosicence). Data were analyzed using FlowJo software (Tree Star 
Inc.) and normalized to the proliferation of naïve cells within each individual experiment.
Cytokine assay
The Bioplex 200 platform (Biorad) was used to efficiently determine the concentration (in pg/ml) 
of multiple target proteins in mGRP-engrafted B6 and scid mouse serum, according to the 
manufacturer’s protocols using the supplied cytokine standards. The concentration was determined 
using a 5-parameter log curve fit using the supplied software. The Mouse Group I 23 plex panel 
was used to measure IL-1α, IL-1β, IL-2, IL-3, IL-4, IL-5, IL-6, IL-9, IL-10, IL-12 (p40), IL-12 
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(p70), IL-13, IL-17A, Eotaxin, G-CSF, GM-CSF, IFNγ, KC, MCP-1, MIP-1α, MIP-1β, RANTES 
and TNFα. The levels of TGFβ were assessed separately (Biorad).
Treg analysis
Intracellular cytokine staining was performed according to the manufacturer’s protocol. Briefly, 
cells were washed, stained for surface markers, fixed with BD Cytofix/Cytoperm, permeabilized, 
and incubated with antibodies against intracellular markers for 40 min on ice. Flow acquisition was 
performed on a LSRII flow cytometry (BD Biosicence), and data were analyzed using FlowJo 
software (Tree Star Inc.). Fluorochrome-tagged antibodies were: CD4-PB (eBioscience-RM4-5), 
CD8-FITC (BD Pharmingen-53-6.7), CD25-PE (BD Pharmingen-PC61), and FoxP3-PerCP-Cy5.5 
(eBioscience-JFK-16s).
MiRNA analysis
RNA isolation was performed with mouse plasma using a miRCURY RNA Isolation Kit Biofluids 
(Exiqon) according to the manufacturer’s protocol. For isolation, 100 μl of plasma was used and 
one step of DNase treatment was added. RNA Spike-in U6 template was added to the mixture as 
an internal control. Purity and quantity of the isolated miRNA were measured with NanoDrop 
photometry. The RNA samples were diluted with nuclease-free water to concentration of 5 ng/μl 
and 2 μl of RNA was used for synthesis of first-strand cDNA using a miRCURY LNA Universal 
RT microRNA PCR kit (Exiqon) according to the manufacturer’s protocol. Real-Time PCR was 
performed with ExiLENT SYBR-Green master mix with LNA Primers specific for miRNAs (let 
7a/7c, miR-125b, miR-146, miR-150, miR-223) (Exiqon). Results determined the changes in 
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steady-state miRNA levels of a gene across multiple samples, and were expressed relatively to the 
pre-transplantation levels and the levels of an internal control RNA.
Supplementary methods
The Supplementary Materials provide further details for immunohistochemical analysis, MRI, 
erichrome cyanin staining, transmission electron microscopy and g-ratio measurement, and 
miRNA in situ hybridization.
Statistical analysis
Data are expressed as mean ± standard deviation (SD) or median [interquartile range]. No animals 
(despite dropouts) or samples were excluded from the analysis. For investigation of GRP survival 
and cytokine assay, regression analysis was reported as type III tests of fixed effects, with the 
lowest mean square (LMS) difference test used for comparison between means (PROC MIXED, 
SAS 9.2). A coefficient of determination was calculated, and the BLI data were subjected to logistic 
transformation to maximize the model fit. CD45, Iba-1 and CD68 immunohistochemical analysis 
and GFP-MBP co-localization were assessed using a 2-sided Kruskal-Wallis test with Bonferroni’s 
adjustment. One way ANOVA with Bonferroni’s adjustment was used for T cell infiltration and 
miRNA analysis, and an independent t-test (2-tailed) was performed for mixed lymphocyte 
reaction and Treg analysis. Mann-Whitney test for g-ratio analysis (SPSS 22.0). Sample size, 
statistical methods, and p values are given in figure legends. Significance was defined at p<0.05.
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Study approval
All experimental procedures were in accordance with the guidance provided in the Rodent Survival 
Surgery Manual and were approved by Johns Hopkins Institutional Animal Care and Use 
Committee (MO14182).
Data availability
The authors declare that all data supporting the findings of this study are available within the article 
and its Supplementary Materials, or from the authors upon reasonable request.
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Results 
Costimulation blockade induces engraftment of GRP allografts in immunocompetent adult 
B6 mice.
Allogeneic GRP survival was first assessed in immunocompetent adult B6 mouse brains and the 
phenotypic identity of mGRPs was verified by immunocytochemistry with different cell lineage 
markers. These cells expressed high levels of A2B5, PDGFRα, NG2, Nestin, Olig1 and Olig2. 
They were negative for Iba-1, CD11b, β-tubulin and MBP. Some cells were GFAP-positive 
reflecting the bidirectional differentiation capacity of GRPs (Rao et al., 1998) (Supplementary Fig. 
1). Membrane proteins PDGFRα (Tsai et al., 2016), NG2 (Biname et al., 2013), PLP (Harlow et 
al., 2014; Harlow et al., 2015) (Supplementary Fig. 1), CXCR4 (Tsai et al., 2016), and FGFR 
(Bribian et al., 2006) (Supplementary Fig. 2) were reported to mediate oligodendrocyte precursor 
migration and were positive in mGRPs.
After mGRP transplantation to the forceps minor of the corpus callosum, a location known for its 
capacity of robustly rejecting GRP allografts (Janowski et al., 2014), scid, CoB and control mice 
all displayed BLI signal decline within the first three weeks. There was a complete signal loss in 
control mice, but scid and CoB mice exhibited a persistent mGRP signal until the endpoint of the 
study (203 days). Both scid and CoB groups showed a statistically significant difference from 
control group (p<0.05) from POD14 onwards (Fig. 1A). To investigate whether additional CTLA4-
Ig-based treatment may enhance the survival of mGRPs, five randomly selected CoB mice (booster 
group) received monthly CTLA4-Ig treatment, mimicking a clinically effective 
immunosuppression maintenance strategy (Kirk et al., 2014). No difference in graft survival was 
observed between non-booster (CTLA4-Ig and MR-1 treatment on POD0, 2, 4 and 6) and booster 
(additional CTLA4-Ig treatment on POD30, 60, 90) groups (Supplementary Fig. 3).
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To test systemic hyporesponsiveness against donor antigens, secondary subcutaneous injections of 
mGRPs isolated from the donor of the original brain grafts were performed after 120 days of 
primary intracerebral grafting in randomly selected CoB (n=3) and scid mice (n=3). Resembling 
the survival curve of primary intracerebral transplantation, naïve B6 controls (n=5) rejected 
subcutaneously transplanted mGRPs within three weeks. Scid and CoB mice, however, accepted 
both primary (brain) and secondary (subcutaneous) mGRP allografts (Fig. 1B). After 17 days of 
secondary subcutaneous transplantation (POD137 of intracerebral transplantation), BLI signals 
were significantly higher in both CoB and scid mice compared to naïve controls (p<0.001 on all 
time-points examined). Signals were detectable for 83 days after secondary transplantation until 
animals were sacrificed for post-mortem assessment (=overall 203 days of investigation, the 
endpoint of the study) (Fig. 1B, C).
Adoptive-T cell transfer experiments were performed to provide evidence for systemic 
hyporesponsiveness rather than sequestration of the grafts behind the BBB. T cells were isolated 
from a naïve B6 mouse, CoB, and control mice (POD154 of intracerebral mGRP transplantation, 
indefinite engraftment was regarded to be established), and were retro-orbitally injected into scid 
mice with different donor configurations (n=4/group). Four days later, mGRPs were 
subcutaneously transplanted to the back of these scid mice. BLI revealed that scid mice receiving 
naïve T cells showed a significant drop in BLI signal 7 days after mGRP transplantation, indicating 
a fast rejection process. Scid mice receiving control T cells exhibited more robust rejection 
indicating a priming effect upon mGRP inoculation. However, the BLI signals in scid mice 
receiving T cells from the CoB-treated mouse was maintained, demonstrating donor-specific 
hyporesponsiveness towards mGRPs primarily engrafted in the brain (Fig. 1D). 
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Histological examination performed to confirm cell survival and identification revealed strong 
expression of GFP under the oligodendrocyte-specific PLP promoter in CoB and scid mouse brains 
(POD154). Elaborate processes indicated maturation of grafted cells towards myelinating 
oligodendrocytes. There was no leukocyte recruitment in CoB brains as examined by CD45 
staining (Fig. 1E).
Human GRPs were transplanted into B6 brains to investigate whether costimulation blockade was 
effective in protecting intracerebral xenografts. Earlier rejection of hGRPs than mGRPs was 
observed in control group starting from POD3, and was completed within two weeks post 
transplantation. In contrast, hGRPs survived well in CoB group by POD19, the endpoint of the 
study. There was no difference in hGRP survival between CoB and scid mice (Supplementary Fig. 
4).
Costimulation blockade prevents immune reaction against GRP allografts.
To characterize the underlying immune response allowing for allogeneic GRP survival, the extent 
and type of cellular infiltrate at the location of intracerebral mGRP injection were evaluated by 
panleukocyte marker CD45, T cell marker CD3, microglial/macrophage marker Iba-1, and active 
phagocyte marker CD68 immunostaining. Mouse brains were harvested at the peak of rejection as 
monitored by rapidly diminishing BLI signals in the control group (POD19). As expected, intense 
immune cell infiltration was detected around the mGRP grafts in control brains, yet only limited 
immune cell recruitment was observed in scid and CoB-treated mouse brains (Fig. 2A). 
Quantitative analysis of CD45 infiltration by both CD45 positive area (Fig. 2B, C) and fluorescent 
intensity (Fig. 2B, D) revealed statistically significant differences between control and CoB group, 
the latter being at a comparative level to scid brains. Of note, mGRPs in control brains were clotted 
and exhibited necrotic morphology on POD19. In contrast, mGRPs in CoB-treated and scid mouse 
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brains appeared vital and extended multiple processes, suggesting the integration of grafts into the 
host brain structure (Fig. 2A and Supplementary Fig. 5).
Excellent graft survival in scid mice revealed the pivotal role that T cells play in immune rejection. 
Investigations on infiltration of the graft site by T cells were performed after intracerebral mGRP 
transplantation. Not surprising, a large number of CD3-positive cells were detected encompassing 
the grafts in the control group. In contrast, T cells were absent in CoB and scid groups as shown 
by quantitative analysis of cell counts (Fig. 2E, F). Accordingly, the Foxp3 staining was negative 
in CoB and scid brains (data not shown). Interestingly, the proportion of Foxp3+ Tregs among 
CD4+ T cells was significantly decreased in CoB spleen on POD5 as compared to control mice, 
which further decreased on POD12 (Supplementary Fig. 6). These data implied that the CoB-
mediated immunomodulation was not Treg dependent.
Quantitative analysis of Iba-1 immunofluorescence at POD19 was performed to identify local 
inflammatory and immune reactions. Although Iba-1 intensity was not different between CoB and 
control groups (Fig. 3A, B), control brains had a much larger Iba-1-positive area surrounding the 
grafts compared to CoB and scid brains (Fig. 3C) being indicative of extensive phagocyte 
recruitment to control brains, which was abrogated by CoB treatment. Next, we further analyzed 
the phagocytic activity by CD68 fluorescent staining, which revealed significantly weaker intensity 
(Fig. 3D, E) and smaller areas (Fig. 3D, F) in CoB brains than in control brains. There was no 
difference in CD68 intensity and positive area between CoB and scid brains.
We further analyzed the peripheral cytokine profiles by a high throughput multiplex bead-based 
immunoassay to investigate the molecular mechanism mediating allograft acceptance (from early 
graft implantation to complete rejection in control mice). Out of 20 cytokines that were within the 
detection range, both the pro-inflammatory IL-1β, IL-5, IL-12(p70), MCP-1, MIP-1β, MIP-1α, IL-
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17, and TNFα, and anti-inflammatory IL-10 and IL-13 were increased in CoB sera as compared to 
control sera on POD5 while IL-1α (pro-inflammation) levels were decreased in CoB sera. The 
differences between CoB and control mice regarding these cytokine levels diminished gradually 
on POD11 and POD17. The expression levels of IL-1β, IL-12(p70), and MIP-1β in control mice 
exceeded those in CoB mouse on POD25, and there was more chemokine RANTES in control sera 
than in CoB sera on POD25 indicating a pro-inflammatory transition in the control group. 
Moreover, the dynamic changes of IL-12(p70) in CoB mice resembled the scid pattern, but was 
different from the control levels which were low in the early post-implantation period, but 
gradually elevated and exceeded the CoB and scid levels by POD17 and 25, respectively. The 
levels of IL-12(p40), antagonist of IL-12(p70), were higher in control mice when compared to CoB 
mice at all time-points examined. IL-10, a major anti-inflammatory cytokine, was expressed at 
similar and elevated levels in CoB and scid mice on POD5 as compared to control mice 
(Supplementary Fig. 7, a clustered heatmap shown in Supplementary Fig. 8). These results 
indicated that the transplantation induced pro-inflammatory cytokine profile was mitigated by 
costimulation blockade.
Costimulation blockade-protected allogeneic GRPs myelinate adult shiverer mouse brains.
We further aimed to utilize the costimulation blockade strategy for allogeneic GRP treatment. 
MGRPs were injected into unilateral corpus callosum of adult myelin basic protein (MBP) deficient, 
thus congenitally hypomyelinated, shiverer (Lachapelle et al., 1983) and immunodeficient shiverer 
(shiverer-rag2-/-, shiverer-rag2) mice. Longitudinal BLI revealed that mGRPs could not survive in 
immunocompetent shiverer mice and were depleted from the host brains within three weeks after 
transplantation, replicating the dynamics shown in our wild-type animal mGRP transplant 
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experiments (Fig. 1). Despite an initial cell loss in shiverer-CoB and shiverer-rag2 mice during the 
first three weeks after transplantation, mGRP signals were consistently detected until the end of 
the natural lifespan of shiverer mice (POD90). Statistical differences were observed between 
shiverer-control and shiverer-CoB groups in mGRP survival from POD14, with no further changes 
in BLI thereafter. In addition, the survival of mGRPs in shiverer-CoB mice was at comparable 
levels to that in immunodeficient shiverer-rag2 mice (p>0.05 at all time-points examined, Fig. 4A, 
B). 
Mixed lymphocyte reactions were carried out to assess systemic T cell responsiveness upon 
costimulation blockade in shiverer mice on POD33. T cells were isolated from naïve shiverer, 
shiverer-CoB and shiverer-control mouse spleen (n=3/group) and cultured together with mGRPs 
(either intact or minced (to expose the intracellular antigens)) in the presence of either donor-
matched allogeneic or third party derived dendritic cells serving as APCs. Both CD4+ and CD8+ T 
cells obtained from shiverer-CoB mice showed reduced proliferation when co-cultured with either 
intact or minced mGRPs in the presence of donor-matched or third party derived APCs as 
compared to shiverer-control levels. These data indicated that CoB induces T cell 
hyporesponsiveness against mGRP antigens both in vivo and in vitro (Fig. 4C, D).
Shiverer mice were subjected to MR scanning to non-invasively visualize the behavior of 
allogeneic GRPs in vivo and to investigate whether immunoprotected mGRPs integrate 
functionally into the hosts and generate mature myelin. While T2-weighted images showed 
excellent white-gray matter contrast in age-matched rag2-/- mice (Fig. 5A), the T2 contrast was 
practically absent (except for the vertical needle tracts) in shiverer-control mice on POD60 and 
POD90. There was no visible discrimination of white matter on POD60 in shiverer-CoB and 
shiverer-rag2 brains, neither. However, on POD90, shiverer-CoB and shiverer-rag2 brains 
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displayed hypointensities along the corpus callosum in the injection side in T2 weighted images 
indicating mGRP-induced myelination (Fig. 5B).
Next, we examined MBP immunostaining in mGRP transplanted shiverer mouse brains. On 
POD33, allogeneic GRPs survived and migrated along the corpus callosum in shiverer-CoB mouse 
brains, and MBP was re-expressed in shiverers being co-localized with PLP-GFP-positive mGRPs 
(co-localization parameters shown in Supplementary Table 1). Furthermore, mGRP derived 
oligodendrocytes and MBP expression widely spread across the injection sites and the ipsilateral 
corpus callosum in shiverer-CoB and shiverer-rag2 brains on POD90. On the contrary, there was 
neither allogeneic GRPs nor MBP expression in shiverer-control brains on POD90 (Fig. 5C, D).
Erichrome cyanin staining was performed to examine the hydrophobic compartment within myelin 
proteins and lipid molecules to verify the myelin integrity in mGRP-engrafted shiverer mice. 
Although MBP could be detected on POD33 in shiverer-CoB mice, erichrome staining was 
negative in these animals indicating that myelin was not yet generated. On POD73 and POD90, 
mature myelin formation could be verified by erichrome-positive staining along the ipsilateral 
corpus callosum in shiverer-CoB and shiverer-rag2 mice (Fig. 6A).
Transmission electron microscopy was carried out to confirm allogeneic mGRP-derived myelin 
formation in shiverer mice. Numerous normally compact myelin sheaths were observed in shiverer-
CoB mouse corpus callosum on POD90. There were few myelinated axons with thin myelin 
sheaths being loosely wrapped in shiverer-control brains (Fig. 6B). The thickness of myelin, 
assessed by g-ratio, was 0.9214[0.873-0.9482] and 0.8071[0.706-0.898] in shiverer-control and 
shiverer-CoB brains, respectively (p<0.0001). This is consistent with previous reports (Gansmuller 
et al., 1986). 
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Circulating miRNAs are potential biomarkers for early detection of graft status.
As costimulation blockade provided a new strategy for intracerebral graft acceptance, we compared 
the expression of several immunoreactivity-linked miRNAs (Hoefig and Heissmeyer, 2008; 
Schjenken et al., 2016; Gaudet et al., 2017) in CoB and control B6 mouse plasma after intracerebral 
mGRP transplantation to explore potential graft rejection/acceptance biomarkers. A number of 
miRNAs were differently expressed between control and CoB mice. For instance, MiR-146 was 
upregulated gradually in control B6 mice after mGRP transplantation, reaching an approximately 
17/12-fold expression level by POD12/19, the time of active rejection. However, in CoB mice, 
miR-146 levels were clearly downregulated, reaching undetectable levels on POD5/12 and 
recovered to sham-transplantation levels on POD19. Likewise, MiR-223 was increasingly 
upregulated in graft-rejecting control mice with statistical difference between POD5 and POD12, 
while its expression decreased in CoB mice after POD2. The opposite trend was observed for Let 
7a/7c for which expression steadily increased in CoB mice until POD19 with reduction observed 
in rejecting control mice until POD12. Levels returned to those observed in vehicle-transplanted 
mice when rejection was close to completion on POD19. While the expression of miR-150 did not 
show differences between different observation days in control mice, it was downregulated 
gradually in CoB group. The levels of miR-125b in the plasma decreased gradually in control mice 
from POD2 to POD12. Its levels in CoB mice remained lower than in control mice (Fig. 7B-F). 
The vehicle-transplanted CoB group and sham-operation group did not show temporal differences 
in these miRNA levels, which excluded the costimulation blockade or surgery induced miRNA 
changes. In situ hybridization revealed higher peri-graft miRNA-146 in control than in CoB brains 
(relative fluorescent intensity 1.551 vs. 1.000, p<0.0001), while neither higher expression nor inter-
group difference were observed for miRNA-233 (Supplementary Fig. 9).
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Discussion 
Thus far, the use of allogeneic stem cells to restore cerebral cytostructure and function is precluded 
by a lack of efficacy due to graft rejection, as well as negative effects of required 
immunosuppression protocols in attempts ensuring graft survival. In the current study, combined 
costimulation blockade using CTLA4-Ig and MR-1 successfully prevented allograft rejection from 
adult mouse brains. Furthermore, immunoprotected allogeneic GRPs differentiated and initiated 
myelination in the dysmyelinated adult mouse brain within one month, which could potentially 
represent an attractive option for patients with dysmyelinating diseases. In addition, several 
microRNAs including miR-146, miR-223, and let 7a/7c were identified as promising graft 
acceptance/rejection biomarkers.
In modern transplantation medicine, immunomodulatory strategies have entered the clinical arena 
to achieve graft survival with reduced toxicity or even immunosuppression-free stages (Diehl et 
al., 2017). Our study showed that costimulation blockade in immunocompetent hosts resulted in 
long-term allogeneic GRP survival matching that in immunodeficient mice. These results align 
well with previous reports on the prevention of rejection in small and large animal models of organ 
transplantation using CTLA4-Ig and MR-1 (Larsen et al., 1996; Bluestone et al., 2006; Gilson et 
al., 2009; Szot et al., 2015; Webber and Vincenti, 2016). Several cell transplantation studies used 
costimulation blockade approaches for intracerebral transplantation of human embryonic stem cell-
derived neural stem cells with cell survival for up to 56 days after grafting (Pearl et al., 2011). 
CTLA4-Ig has also been applied to prevent rejection of human CD34+ hematopoietic cells. Good 
cell survival at 56 days was achieved when mice were injected with blocking antibodies over 27 
days after grafting, but cells were rejected when treatment was maintained for only 13 days (Oh et 
al., 2017). We successfully push forward this strategy and observe intracerebral mGRP survival 
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for more than 200 days with functional integration. However, while this study sought to investigate 
the survival and myelination capacity of allogeneic GRPs under the protection of costimulation 
blockade, we transplanted GRPs to unilateral corpus callosum, with the contralateral hemisphere 
serving as an internal control. The small amount of locally transplanted GRPs were not sufficient 
to rescue the phenotype of shiverer mice that exhibit global demyelination. The therapeutic dose 
as well as the optimal route of GRP transplantation await detailed investigation.
Costimulation blockade effectively prevented local immune reactions with significantly less 
phagocyte reactivity and T cell infiltration around the mGRP allografts in CoB-treated mice 
compared to untreated immunocompetent controls. However, it is important to expand our 
investigation into the nature of the immunomodulatory effects and answer whether costimulation 
blockade effects are elicited exclusively in the CNS or, alternatively, in a systemic fashion. This is 
particularly relevant since peripheral maladaptive immune responses are already in place in many 
demyelinating disorders such as MS. We showed that subcutaneous injection of donor-matched 
GRPs into recipients with primary, intracerebrally-engrafted GRPs resulted in good cell survival 
in the CoB group with rejection in the controls supporting a state of systemic hyporesponsivness 
rather than a protective effect of the BBB. This is important as otherwise any local BBB breach in 
the course of brain injury or inflammation could trigger rejection processes. Evidence of systemic 
tolerance is also encouraging in the context of repetitive therapeutic application of 
immunologically matched stem cells. 
We have demonstrated here that CoB is also effective in protecting xenografted human GRPs. This 
is highly significant as it allows studying behavior of human cells in various available transgenic 
mouse models or disease systems where adaptive immunity plays important role such as stroke or 
multiple sclerosis. We have recently shown that similar strategy with CoB can be used for modeling 
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human glioblastoma in immunocompetent mice (Semenkow et al., 2017) further demonstrating 
universal utility of this method.
Costimulation blockade induced dynamic changes in the serum cytokine network during systematic 
allograft acceptance. It has been reported that inhibition of CD28-B7 interaction could alter 
cytokine profiles from Th1 to Th2 (Lin et al., 1997). Moreover, Th1 and Th2 cells were 
differentially regulated by CD28-B7 versus CD154-CD40 costimulation pathways in vivo 
(Kishimoto et al., 2000). While the serum cytokine expression differences between CoB and 
control groups diminished gradually after initial elevation on both Th1 and Th2 cytokines in CoB 
group, IL-1β, IL-12(p70), RANTES and MIP-1β levels steadily increased in control group and 
exceeded the CoB levels at POD25. Together with IL-12(p40) expression, whose levels were 
sustained high in control group, transition to pattern of Th2 cytokine expression might be a major 
player mediating costimulation blockade dependent immune tolerance induction. 
Although Tregs are important regulators for alloimmune responses (Adams et al., 2016) in organ 
and cell transplantation (Camirand and Riella, 2017), the effects of costimulation blockade on 
Tregs is still unclear. It was assumed that co-stimulation blockade inhibits Treg survival and 
function (Adams et al., 2016), and an in-vitro study showed that CTLA4-Ig inhibited Treg 
proliferation (Levitsky et al., 2013). Tolerance induced by costimulation blockade for human 
embryonic stem-cell-derived pancreatic endoderm was shown to be independent on Tregs (Szot et 
al., 2015). Flowcytometric analysis indicated that CTLA4-Ig did not induce Treg expansion in 
peripheral blood of transplanted patients (Chavez et al., 2007). We show that GRP allografts were 
not negatively affected although Tregs were decreased in CoB-treated recipients. In addition, we 
could not detect infiltrating T cells as well as Foxp3 T cells into the CoB brain after GRP 
engraftment. Due to limited studies regarding Treg activities in the brain as well as across the BBB, 
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the role of systemic Treg cells on the intracerebral mGRP allografts needs further mechanistic 
studies.
This study yields highly encouraging results on potential peripheral surrogate miRNAs for graft 
rejection as their specific temporal pattern correlated with survival or rejection of allogeneic GRPs. 
In addition, our results are supported by previous studies showing that miR-223 and miR-146 were 
both overexpressed, while let 7 levels were downregulated, in renal biopsies with confirmed T-cell 
mediated acute rejection compared to normal allografted patients (Anglicheau et al., 2009). In rat 
liver transplantation settings, miR-223 and miR-146 levels were also significantly increased in 
allografts with acute rejection (Hu et al., 2013; Morita et al., 2014). Moreover, MiR-223 levels 
were reported to be highly predictive of acute renal rejection and strongly linked to the intragraft 
expression of CD3 mRNA (Sui et al., 2008; Betts et al., 2014). MiR-146 and miR-223 are produced 
by activated macrophages and are key anti-inflammatory miRNAs (Gaudet et al., 2017). Their 
upregulation during rejection may reflect a negative feedback for inflammatory responses. The 
increased intragraft miR-146 expression and good graft survival confirmed its tolerance promotion 
property. The Let 7 miRNA family promotes both anti- and pro-inflammatory actions (Gaudet et 
al., 2017). The miR-125b-let 7c-miR-99a cluster buffers against aberrant self-renewal and 
differentiation of hematopoietic stem cells by simultaneously targeting TGFβ and WNT1 signaling 
and plays a role in the development of Th1 cells (Mehta and Baltimore, 2016). Thus, dynamic 
profiles of miRNAs could be evaluated as potential biomarkers for monitoring graft survival and 
may help to improve the overall prognosis of patients with neurological disorders undergoing GRP 
transplantation.
In conclusion, this study demonstrates the efficacy of a combined costimulation blockade-based 
immunomodulatory protocol to achieve survival and retain (re)myelination capacity of allogeneic 
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GRPs transplanted directly into the murine CNS. In addition, we show that miRNAs may represent 
a meaningful tool for monitoring allograft viability, specifically in anatomical areas inaccessible 
to conventional methods. These encouraging data may foster the advancement of allogeneic GRPs’ 
potential to enhance functional recovery in dysmyelination disorders in both translational large 
animal models and humans.
Acknowledgments
We would like to thank Mary McAlister for editorial assistance. 
Funding
This study was funded by NIH/NINDS R01NS091110, R01NS091100, R01NS102675, 2017-
MSCRFD-3942.
Competing interests 
The authors report no competing interests.
Page 27 of 71
ScholarOne, 375 Greenbrier Drive, Charlottesville, VA, 22901  Support (434) 964 4100
Brain
For Peer Review
28
Supplementary Materials
Supplementary Methods
Immunohistochemical analysis
Mice were anesthetized and perfused intracardially with 5% sucrose followed by PBS-buffered 4% 
paraformaldehyde. Brains were taken out, postfixed overnight at 4°C in 4% paraformaldehyde, 
dehydrated in 30% sucrose (Sigma-Aldrich), snap-frozen, and cryosectioned (Thermo Scientific 
HM 550 Cryostat) into 30-µm coronal sections. Nonspecific binding was blocked by incubating 
with 10% donkey serum in 0.1% Triton X-100-PBS for 1 h at room temperature. Appropriate 
dilutions of primary antibodies were then applied in blocking solution overnight at 4°C. After three 
washes, the corresponding secondary antibodies (in blocking solution, Alexa Fluro-594, Life 
Technologies-A11058) were incubated for 1 h at room temperature. Sections were then rinsed with 
PBS, counterstained with DAPI, and mounted with aqueous non-fluorescence mounting medium 
(Immu-mount, Thermo Scientific). Images were acquired with a Zeiss AX10 fluorescence 
microscope using the same exposure time and quantified with Image J. Primary antibodies were: 
anti-CD45 (1:500, Serotec-MCA1388); anti-Iba-1 (1:250, Wako-SAN3725); anti-CD3 (1:200, 
R&D-MAB4841); anti-CD68 (1:100, Abcam-ab31630); anti-MBP (1:1000, Serotec-MCA409S); 
anti-human cytoplasmic marker STEM121 (1:250, StemCells-AB-121-U050). The co-localization 
parameters between GFP and MBP was analyzed using Image-Pro Plus 6.0.
MRI
In-vivo MRI was performed on a horizontal 11.7 Tesla MR scanner (Bruker Biospin) with a triple-
axis gradient (maximum gradient strength=74 Gauss/cm). During imaging, mice were anesthetized 
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with 1% isoflurane in room air and oxygen mixed at 3:1 ratio via a vaporizer, and positioned in an 
animal holder containing circulating warm water (Bruker Biospin). Respiration was monitored via 
a pressure sensor (SAII, Stony Brook) and maintained at 40-60 breath/min. After imaging, animals 
recovered within 5 min.
Image acquisition was performed using a quadrature transmit volume coil (70-mm diameter) and 
a 4-channel mouse brain receive-only phased array coil (Bruker Biospin). Multi-slice T2-weighted 
images were acquired using the rapid acquisition with refocused echoes (RARE) sequence with an 
echo time (TE) of 50 ms, a repetition time (TR) of 3600 ms, four signal averages, echo train length 
of eight, field of view (FOV) of 15x15 mm, 32 slices, and a native resolution of 0.078x0.078x0.50 
mm.
Erichrome cyanin staining
Slides were oven-dried at 50°C for 3 h, hydrated in 95% and 70% ethanol. After rinsing with 
distilled water twice, the sections were stained with an erichrome cyanine solution consisting of 
0.4% FeCl3, 0.2% erichrome cyanine (Sigma-Aldrich) and 0.5% H2SO4. Section development was 
performed by alternating exposure to 0.1% NH4OH for 3-7 s and rinsing in distilled water for 30 s 
until the blue background was reduced and cells turned faintly pink but still had blue shading. After 
the last rinse in water, sections were dehydrated in 70%, 95%, and 100% ethanol (two changes), 
and three changes of xylene for 10 min each before being processed for microscopy.
Transmission electron microscopy and g-ratio measurement
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Perfused shiverer mouse brains were placed under a fluorescent dissection microscope. A 3-mm 
diameter cube was dissected from the mGRP transplanted corpus callosum and fixed in 4% 
glutaraldehyde following postfixation in OsO4, and embedded in Epon. Thin sections of 70 nm 
were stained with citrate/uranyl acetate as recently described (Lyczek et al., 2017). Images were 
acquired using a Zeiss Libra transmission electron microscope from the upper left field and then, 
in a “zigzag” fashion with equidistant movement. G-ratio was measured as inner/outer diameter of 
the myelin sheath (300 axons per animal).
MiRNA in situ hybridization
In situ hybridization (ISH) for miR-223 and miR-146 (miRCURY LNA miRNA probes, Exiqon) 
was performed using miRCURY LNA microRNA ISH Kit (Exiqon) according to manufacturer’s 
protocol. In brief, cryosections were air dried at room temperature and treated with Proteinase-K 
for 10 min, washed twice in PBS. Hybridization mix was then applied for 60 min at 52°C following 
washes in descending concentrations of SSC buffers. Next, sections were incubated sequentially in 
blocking solution for 15 min and anti-DIG reagent conjugated with rhodamine (Roche) for 60 min. 
After three washes with PBS and counterstained with DAPI, slides were mounted with Floro-Gel 
Mounting Media (EMS) and imaged with ZEISS AX10 fluorescence microscope.
Supplementary Figure legends
Supplementary Fig. 1. Spinal cord-derived mGRPs express macroglial lineage but not 
neuronal markers. PLP-GFP-positive mGRP cells were isolated from E13.5 mouse spinal cord 
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and cultured in selection medium for 10 days. Immunocytochemistry was performed against 
multiple marker antigens indicated at the upper right corners of each images. Scale bar: 50 µm.
Supplementary Fig. 2. Immunocytochemistry for migration-mediating molecules. PLP-GFP-
positive mGRP cells were isolated from E13.5 mouse spinal cord and cultured in selection medium 
for 10 days. Immunocytochemistry was performed with (A) CXCR4 and (B) FGFR antibodies. 
Scale bar: 50 µm.
Supplementary Fig. 3. Additional CTLA4-Ig application does not further enhance graft 
survival. Logarithmic BLI values of non-booster group (MR-1 and CTLA4-Ig treatment on POD0, 
2, 4, 6, n=5), booster group (additional CTLA4-Ig application on POD30, 60, 90, n=5), and control 
group of B6 mice (n=5) that received intracerebral mGRP transplantation. There was no statistical 
difference between booster and non-booster group at any time-point examined. Both booster (*, 
p<0.05) and non-booster group BLI signals (#, p<0.05) were significantly higher than in the control 
group from POD14 onwards. Regression analysis was reported as type III tests of fixed effects, 
with the lowest mean square (LMS) difference test used for comparison between means (PROC 
MIXED, SAS 9.2). A coefficient of determination was calculated, and the BLI data were subjected 
to logistic transformation to maximize the model fit.
Supplementary Fig. 4. Costimulation blockade protects xenogeneic GRPs from immune 
rejection. Intracerebral hGRP engrafted B6 mice were subjected to longitudinal BLI and the 
logarithmic total flux over their heads were plotted. The statistically significant difference between 
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CoB and control group (*, p<0.05, n=5) started from POD9 and lasted till POD19. There were no 
BLI signal differences between CoB and scid groups (p>0.4, n=5). Regression analysis was 
reported as type III tests of fixed effects, with the lowest mean square (LMS) difference test used 
for comparison between means (PROC MIXED, SAS 9.2). A coefficient of determination was 
calculated, and the BLI data were subjected to logistic transformation to maximize the model fit. 
(B) Immunohistochemistry on B6 and scid mouse brain specimens was performed with STEM121 
antibodies and DAPI staining on POD19. Scale bar: 100/10 µm in low/high magnificent images.
Supplementary Fig. 5. GRPs are vital after 19 days of intracerebral transplantation with 
costimulation blockade treatment. Confocal microscopy for PLP-GFP-positive mGRPs being 
transplanted into CoB, scid and control mouse brains on POD19. Cell nuclei were stained with 
DAPI. Note that mGRPs extended complex processes in CoB and scid brains indicating the 
integration into host brains, but displayed moribund morphology in control brains. Scale bar: 10 
µm.
Supplementary Fig. 6. Peripheral Treg population is decreased in costimulation blockade 
treated mice. T cells isolated from naïve, control and CoB B6 mouse spleens were analyzed for 
the proportion (A) and absolute number (B) of CD4+, FoxP3+ Tregs by flow cytometry. Control 
mice had significantly more Tregs residing in the spleen than CoB mice on both POD5 (p<0.0001) 
and POD12 (p=0.0016). There was no difference in neither CD4+ cell proportion (C) nor absolute 
numbers (D). Independent two sample t-test (SPSS 22.0).
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Supplementary Fig. 7. Costimulation blockade mitigates the post-transplantation pro-
inflammatory cytokine profile. Sera from intracerebrally mGRP transplanted CoB, control, and 
scid mice were drawn on POD5, 11, 17, 25 and subjected to a high throughput cytokine analysis. 
Cytokines that were within the detection range are presented with absolute values and standard 
deviation at different time-points examined. One-way ANOVA with LSD post hoc corrections. 
*p<0.05 between CoB and control mice, &p<0.05 between CoB and scid mice, #p<0.05 between 
scid and control mice (n=5 in each group). 
Supplementary Fig. 8. Clustered heatmaps of the serum cytokines after intracerebral mGRP 
transplantation. Sera from intracerebral mGRP transplanted CoB, control, and scid mice were 
drawn on POD5, 11, 17, 25 and subjected to a high throughput cytokine analysis. Cluster analysis 
was performed with NCSS Statistical Software based on the quantitative data presented in 
Supplementary Fig. 7.
Supplementary Fig. 9. Costimulation blockade upregulates intragraft miR-146 expression 
post mGRP transplantation. In situ miRNA hybridization with DAPI counterstaining was 
performed for mGRP transplanted CoB and control mouse brains on POD19. (A) Mouse brain 
cryosections were hybridized with miR-146 probes and note its increased expression co-localizing 
with mGRPs in CoB brains. Control brains were negative for miR-146 hybridization. (B). Mouse 
brain cryosections were hybridized with miR-223 probes. There was no positive hybridization in 
neither CoB nor control brains. Scale bar: 50 µm.
Supplementary Table 1. GFP-MBP co-localization parameters.
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Table 1. Animal assignment and measurements.
Animal number
B6
CoB
B6
control
scid
Endpoint
(day)
Measurements
5A + 5B 5C 5D 203 • mGRP allograft survival (BLI)
•secondary mGRP allograft survival (BLI)
•adoptive transfer 
•immunohistochemistry
•cytokine analysis
5 5 5 19 •IHC
5 5 5 •miRNA analysis, Treg analysis
5 5 12 •miRNA analysis, Treg analysis
10E 10E 19 •miRNA analysis
5 5 5 19 •hGRP xenograft survival (BLI)
Shiverer
-CoB
Shiverer
-control
Shiverer
-rag2
5 5 5 33 •BLI, MLR, IHC, Erichrome staining
5 5 5 90 •BLI, MRI, Erichrome staining, IHC, EM
Anon-booster: CTLA4-Ig+MR-1 on POD0, 2, 4, 6. One sacrificed (on POD154). Bbooster: CTLA4-
Ig+MR-1 on POD0, 2, 4, 6 and monthly CTLA4-Ig. One died (POD50). C: One died (POD57. One 
sacrificed (POD154). D: One died (POD28). One died (POD126). E: Five with mGRP transplantation.
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Figure legends
Fig. 1. Costimulation blockade induces long-term engraftment of allogeneic GRPs. B6 and 
scid mice were recipients for luciferase-expressing mGRPs. (A) Logarithmic BLI total flux over 
the mouse heads was plotted longitudinally for 203 days. Statistically significant difference 
between CoB and control group (*, p<0.05, n=5), and scid and control group (#, p<0.05, n=5) 
started from POD14. (B) On POD120, three CoB and three scid mice received a second, 
subcutaneous mGRP transplantation to their back. Five naïve B6 mice served as controls. BLI 
values were plotted and the statistical difference between CoB and control group started from 
POD17 (*, p<0.05). (C) BLI image of mice that received both intracerebral and subcutaneous 
transplantation of mGRPs (POD203 of intracerebral transplantation). BLI intensity scale is shown 
on the right. (D) T cells isolated from one naïve B6 mouse, one CoB, and one control mouse on 
POD154 were retro-orbitally injected into scid mice with five different combinations (n=4). Four 
days after T cell inoculation, these scid mice received subcutaneous mGRP injection into their back 
and subsequent serial BLI. BLI signals were significantly different between CoB and control group 
on POD7 (p<0.0001). Regression analysis was reported as type III tests of fixed effects, with the 
lowest mean square (LMS) difference test used for comparison between means (PROC MIXED, 
SAS 9.2). A coefficient of determination was calculated, and the BLI data were subjected to logistic 
transformation to maximize the model fit. (E) Immunohistochemistry with anti-CD45 antibodies 
(leukocytes) and DAPI for CoB, control and scid mouse brains on POD154. Note the absence of 
CD45-positive cells in CoB brain. Scale bar: 50 µm.
Fig. 2. T cell recruitment elicited to GRP allografts is abrogated by costimulation blockade. 
(A) CD45 immunostaining was performed for B6 and scid mouse brains on POD19. Scale bar: 
Page 43 of 71
ScholarOne, 375 Greenbrier Drive, Charlottesville, VA, 22901  Support (434) 964 4100
Brain
For Peer Review
44
100/20 µm in low/high magnificent images. (B) Schematic diagram showing the area of mGRP 
engraftment and immune cell infiltration assessment outlined with a red line and covered by a 0.05 
X 0.1 cm rectangle (grey). The red fluorescence intensity in the transplanted side was measured 
and normalized to a corresponding area at the contralateral side (second rectangle) of each mouse. 
(C) Statistical difference was revealed between CoB and control group in CD45-positive areas (*, 
p=0.011), but not between CoB and scid group (p=1.000), n=5. (D) A statistically significant 
difference was revealed between CoB and control group in CD45 intensity (*, p=0.001), but not 
between CoB and scid group (p=0.231), n=5. Independent samples Kruskal-Wallis (2-sided) test 
with Bonferroni’s adjustment (SPSS 22.0). (E) Immunohistochemistry was performed for B6 and 
scid mouse brains with CD3 antibodies and DAPI staining on POD19. T cells were robustly 
recruited around the mGRP allografts in the control group but were absent in CoB and scid groups. 
Scale bar: 50/10 µm in low/high magnificent images. (F) Counting of CD3-positive cells in the 
total brain slices showed that statistically less T cells were recruited to both CoB brains and scid 
brains as compared to control brains (scid versus control, p=0.042, CoB versus control, *, p=0.046) 
and there was no difference between CoB group and scid group (p=1.000), n=5. One way ANOVA 
with Bonferroni’s adjustment (SPSS 22.0).  
Fig. 3. Phagocytic activity against allografts is prohibited by costimulation blockade. (A) Iba-1 
immunostaining was performed for B6 and scid mouse brains on POD19. Scale bar: 50 µm. (B) 
There was no statistical difference between any two groups in Ibal-1 intensity, n=5. (C) Statistical 
difference was revealed between CoB and control group for Iba-1-positive areas (*, p=0.033, n=5), 
but not between CoB and scid group (p=1.000), n=5. (D) CD68 immunostaining was performed 
for B6 and scid mouse brains on POD19. Scale bar: 50 µm. (E) There was statistical difference in 
CD68 intensity between CoB and control group (*, p=0.021), scid and control group (p=0.026), 
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but not between CoB and control group (p=1.000), n=5. (F) Statistical difference was revealed 
between CoB and control group for CD68-positive area (*, p=0.003, n=5), but not between CoB 
and scid group (p=1.000), n=5. Independent samples Kruskal-Wallis (2-sided) test with 
Bonferroni’s adjustment (SPSS 22.0).
Fig. 4. Costimulation blockade induces long-term survival of GRPs in dysmyelinated shiverer 
mice. (A) MGRP engrafted shiverer mice were subjected to longitudinal BLI and the logarithmic 
total flux were plotted. The statistically significant difference between shiverer-CoB and shiverer-
control groups (*, p<0.05, n=5) as well as shiverer-rag2 and shiverer-control groups (#, p<0.05, 
n=5) started from POD14 and lasted until POD90. There were no BLI signal differences between 
shiverer-CoB and shiverer-rag2 groups (p>0.4, n=5). Regression analysis was reported as type III 
tests of fixed effects, with the lowest mean square (LMS) difference test used for comparison 
between means (PROC MIXED, SAS 9.2). A coefficient of determination was calculated, and the 
BLI data were subjected to logistic transformation to maximize the model fit. (B) BLI image of 
mGRP-transplanted shiverer mice (POD90). (C-D) T cells isolated from shiverer-CoB or shiverer-
control mice were co-cultured with either intact or minced mGRPs in the presence of either APCs 
or third party APCs. The proliferation of CD4+ T cells (C) and CD8+ T cells (D) were analyzed by 
flow cytometry and normalized to age-matched naïve shiverer mouse levels. There was a 
statistically significant difference between control and CoB group when cultured with donor-
matched APC in presence of minced mGRP (CD4+, *, p=0.0277, n=3, CD8+, *, p=0.0364, n=3), 
and when cultured with third party-derived APC in presence of intact mGRP (CD4+, *, p=0.0206, 
n=3, CD8+, p=0.0277, n=3). Independent two sample t-test (SPSS 22.0).
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Fig. 5. GRPs engrafted into shiverer mouse brains differentiate into MBP-positive 
oligodendrocytes. (A) T2-weighted image of a 4-month old rag2-/- (rag2) mouse. Scale bar: 5 
mm. (B) MGRP-transplanted shiverer mice were subjected to T2-weighted MRI. Note the 
hypointensity in shiverer-rag2 and shiverer-CoB brains along the corpus callosum (white arrows) 
on POD90. (C) Immunohistochemistry was performed using MBP antibodies and DAPI for 
mGRP-transplanted shiverer mouse brains on POD33 and POD90 (corresponding to the mice 
imaged in (B)). Note that the MBP-positive region co-localized with the engrafted GFP-expressing 
mGRPs. There was neither green nor red fluorescence in shiverer-control mice on POD90. Scale 
bar: 200 µm. (D) Confocal microscopy of POD90 mGRP engrafted shiverer brain to better 
appreciate the cell morphology and GFP-MBP co-localization. Scale bar: 10 µm.
Fig. 6. Protected by costimulation, allogeneic GRPs form myelin in dysmyelinated shiverer 
brains. (A) Erichrome cyanin staining was carried out for mGRP transplanted shiverer mouse 
brains on POD33, 73, and 90. Positive staining was observed along the corpus callosum on POD73 
and POD90 in shiverer-rag2 and shiverer-CoB brains but was absent in shiverer-CoB brain on 
POD33 and shiverer-control brain on POD90. Scale bar: 500 µm. (B) Transmission electron 
microscopy with shiverer corpus callosum at Bregma level in the transplanted hemisphere on 
POD90. Upper images: mGRP transplanted shiverer-CoB. Lower images: mGRP transplanted 
shiverer-control. Left panel, lower magnification. Right panel, higher magnification. Scale bar: 500 
nm. Side length of upper right insets: 300 nm.
Fig. 7. Dynamic changes of miRNA could serve as graft tolerance/rejection biomarkers. 
MiRNA was isolated from CoB and control B6 mouse plasma on POD2, 5, 12 and 19 of 
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intracerebral mGRP transplantation and the expression of miR-146, miR-223, let 7a/7c, miR-150, 
and miR-125b was measured and normalized to their pre-transplantation levels. One way ANOVA 
with Bonferroni’s adjustment, *, p<0.05 between two adjacent time-points in GRPs+PBS or 
GRPs+CoB groups. #, GRPs+CoB vs. GRPs+PBS, &, GRPs+PBS vs. surgery+CoB, §, GRPs+PBS 
vs. surgery+PBS, $, GRPs+CoB vs. sugery+CoB, † GRPs+CoB vs. surgery+PBS, p<0.05 
comparison between two groups at identical time-points (t-test).
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Fig. 1. Costimulation blockade induces long-term engraftment of allogeneic GRPs. B6 and scid mice were 
recipients for luciferase-expressing mGRPs. (A) Logarithmic BLI total flux over the mouse heads was plotted 
longitudinally for 203 days. Statistically significant difference between CoB and control group (*, p<0.05, 
n=5), and scid and control group (#, p<0.05, n=5) started from POD14. (B) On POD120, three CoB and 
three scid mice received a second, subcutaneous mGRP transplantation to their back. Five naïve B6 mice 
served as controls. BLI values were plotted and the statistical difference between CoB and control group 
started from POD17 (*, p<0.05). (C) BLI image of mice that received both intracerebral and subcutaneous 
transplantation of mGRPs (POD203 of intracerebral transplantation). BLI intensity scale is shown on the 
right. (D) T cells isolated from one naïve B6 mouse, one CoB, and one control mouse on POD154 were retro-
orbitally injected into scid mice with five different combinations (n=4). Four days after T cell inoculation, 
these scid mice received subcutaneous mGRP injection into their back and subsequent serial BLI. BLI signals 
were significantly different between CoB and control group on POD7 (p<0.0001). Regression analysis was 
reported as type III tests of fixed effects, with the lowest mean square (LMS) difference test used for 
comparison between means (PROC MIXED, SAS 9.2). A coefficient of determination was calculated, and the 
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BLI data were subjected to logistic transformation to maximize the model fit. (E) Immunohistochemistry 
with anti-CD45 antibodies (leukocytes) and DAPI for CoB, control and scid mouse brains on POD154. Note 
the absence of CD45-positive cells in CoB brain. Scale bar: 50 µm. 
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Fig. 2. T cell recruitment elicited to GRP allografts is abrogated by costimulation blockade. (A) CD45 
immunostaining was performed for B6 and scid mouse brains on POD19. Scale bar: 100/20 µm in low/high 
magnificent images. (B) Schematic diagram showing the area of mGRP engraftment and immune cell 
infiltration assessment outlined with a red line and covered by a 0.05 X 0.1 cm rectangle (grey). The red 
fluorescence intensity in the transplanted side was measured and normalized to a corresponding area at the 
contralateral side (second rectangle) of each mouse. (C) Statistical difference was revealed between CoB 
and control group in CD45-positive areas (*, p=0.011), but not between CoB and scid group (p=1.000), 
n=5. (D) A statistically significant difference was revealed between CoB and control group in CD45 intensity 
(*, p=0.001), but not between CoB and scid group (p=0.231), n=5. Independent samples Kruskal-Wallis (2-
sided) test with Bonferroni’s adjustment (SPSS 22.0). (E) Immunohistochemistry was performed for B6 and 
scid mouse brains with CD3 antibodies and DAPI staining on POD19. T cells were robustly recruited around 
the mGRP allografts in the control group but were absent in CoB and scid groups. Scale bar: 50/10 µm in 
low/high magnificent images. (F) Counting of CD3-positive cells in the total brain slices showed that 
statistically less T cells were recruited to both CoB brains and scid brains as compared to control brains (scid 
versus control, p=0.042, CoB versus control, *, p=0.046) and there was no difference between CoB group 
and scid group (p=1.000), n=5. One way ANOVA with Bonferroni’s adjustment (SPSS 22.0). 
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Fig. 3. Phagocytic activity against allografts is prohibited by costimulation blockade. (A) Iba-1 
immunostaining was performed for B6 and scid mouse brains on POD19. Scale bar: 50 µm. (B) There was 
no statistical difference between any two groups in Ibal-1 intensity, n=5. (C) Statistical difference was 
revealed between CoB and control group for Iba-1-positive areas (*, p=0.033, n=5), but not between CoB 
and scid group (p=1.000), n=5. (D) CD68 immunostaining was performed for B6 and scid mouse brains on 
POD19. Scale bar: 50 µm. (E) There was statistical difference in CD68 intensity between CoB and control 
group (*, p=0.021), scid and control group (p=0.026), but not between CoB and control group (p=1.000), 
n=5. (F) Statistical difference was revealed between CoB and control group for CD68-positive area (*, 
p=0.003, n=5), but not between CoB and scid group (p=1.000), n=5. Independent samples Kruskal-Wallis 
(2-sided) test with Bonferroni’s adjustment (SPSS 22.0). 
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Fig. 4. Costimulation blockade induces long-term survival of GRPs in dysmyelinated shiverer mice. (A) MGRP 
engrafted shiverer mice were subjected to longitudinal BLI and the logarithmic total flux were plotted. The 
statistically significant difference between shiverer-CoB and shiverer-control groups (*, p<0.05, n=5) as 
well as shiverer-rag2 and shiverer-control groups (#, p<0.05, n=5) started from POD14 and lasted until 
POD90. There were no BLI signal differences between shiverer-CoB and shiverer-rag2 groups (p>0.4, n=5). 
Regression analysis was reported as type III tests of fixed effects, with the lowest mean square (LMS) 
difference test used for comparison between means (PROC MIXED, SAS 9.2). A coefficient of determination 
was calculated, and the BLI data were subjected to logistic transformation to maximize the model fit. (B) BLI 
image of mGRP-transplanted shiverer mice (POD90). (C-D) T cells isolated from shiverer-CoB or shiverer-
control mice were co-cultured with either intact or minced mGRPs in the presence of either APCs or third 
party APCs. The proliferation of CD4+ T cells (C) and CD8+ T cells (D) were analyzed by flow cytometry and 
normalized to age-matched naïve shiverer mouse levels. There was a statistically significant difference 
between control and CoB group when cultured with donor-matched APC in presence of minced mGRP 
(CD4+, *, p=0.0277, n=3, CD8+, *, p=0.0364, n=3), and when cultured with third party-derived APC in 
presence of intact mGRP (CD4+, *, p=0.0206, n=3, CD8+, p=0.0277, n=3). Independent two sample t-test 
(SPSS 22.0). 
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Fig. 5. GRPs engrafted into shiverer mouse brains differentiate into MBP-positive oligodendrocytes. (A) T2-
weighted image of a 4-month old rag2-/- (rag2) mouse. Scale bar: 5 mm. (B) MGRP-transplanted shiverer 
mice were subjected to T2-weighted MRI. Note the hypointensity in shiverer-rag2 and shiverer-CoB brains 
along the corpus callosum (white arrows) on POD90. (C) Immunohistochemistry was performed using MBP 
antibodies and DAPI for mGRP-transplanted shiverer mouse brains on POD33 and POD90 (corresponding to 
the mice imaged in (B)). Note that the MBP-positive region co-localized with the engrafted GFP-expressing 
mGRPs. There was neither green nor red fluorescence in shiverer-control mice on POD90. Scale bar: 200 
µm. (D) Confocal microscopy of POD90 mGRP engrafted shiverer brain to better appreciate the cell 
morphology and GFP-MBP co-localization. Scale bar: 10 µm. 
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Fig. 6. Protected by costimulation, allogeneic GRPs form myelin in dysmyelinated shiverer brains. (A) 
Erichrome cyanin staining was carried out for mGRP transplanted shiverer mouse brains on POD33, 73, and 
90. Positive staining was observed along the corpus callosum on POD73 and POD90 in shiverer-rag2 and 
shiverer-CoB brains but was absent in shiverer-CoB brain on POD33 and shiverer-control brain on POD90. 
Scale bar: 500 µm. (B) Transmission electron microscopy with shiverer corpus callosum at Bregma level in 
the transplanted hemisphere on POD90. Upper images: mGRP transplanted shiverer-CoB. Lower images: 
mGRP transplanted shiverer-control. Left panel, lower magnification. Right panel, higher magnification. 
Scale bar: 500 nm. Side length of upper right insets: 300 nm. 
Page 55 of 71
ScholarOne, 375 Greenbrier Drive, Charlottesville, VA, 22901  Support (434) 964 4100
Brain
For Peer Review
 
Fig. 7. Dynamic changes of miRNA could serve as graft tolerance/rejection biomarkers. MiRNA was isolated 
from CoB and control B6 mouse plasma on POD2, 5, 12 and 19 of intracerebral mGRP transplantation and 
the expression of miR-146, miR-223, let 7a/7c, miR-150, and miR-125b was measured and normalized to 
their pre-transplantation levels. One way ANOVA with Bonferroni’s adjustment, *, p<0.05 between two 
adjacent time-points in GRPs+PBS or GRPs+CoB groups. #, GRPs+CoB vs. GRPs+PBS, &, GRPs+PBS vs. 
surgery+CoB, §, GRPs+PBS vs. surgery+PBS, $, GRPs+CoB vs. sugery+CoB, †GRPs+CoB vs. surgery+PBS, 
p<0.05 comparison between two groups at identical time-points (t-test). 
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Supplementary Materials
Supplementary Methods
Immunohistochemical analysis
Mice were anesthetized and perfused intracardially with 5% sucrose followed by PBS-buffered 
4% paraformaldehyde. Brains were taken out, postfixed overnight at 4°C in 4% 
paraformaldehyde, dehydrated in 30% sucrose (Sigma-Aldrich), snap-frozen, and 
cryosectioned (Thermo Scientific HM 550 Cryostat) into 30-µm coronal sections. Nonspecific 
binding was blocked by incubating with 10% donkey serum in 0.1% Triton X-100-PBS for 1 h 
at room temperature. Appropriate dilutions of primary antibodies were then applied in blocking 
solution overnight at 4°C. After three washes, the corresponding secondary antibodies (in 
blocking solution, Alexa Fluro-594, Life Technologies-A11058) were incubated for 1 h at room 
temperature. Sections were then rinsed with PBS, counterstained with DAPI, and mounted with 
aqueous non-fluorescence mounting medium (Immu-mount, Thermo Scientific). Images were 
acquired with a Zeiss AX10 fluorescence microscope using the same exposure time and 
quantified with Image J. Primary antibodies were: anti-CD45 (1:500, Serotec-MCA1388); anti-
Iba-1 (1:250, Wako-SAN3725); anti-CD3 (1:200, R&D-MAB4841); anti-CD68 (1:100, 
Abcam-ab31630); anti-MBP (1:1000, Serotec-MCA409S); anti-human cytoplasmic marker 
STEM121 (1:250, StemCells-AB-121-U050). The co-localization parameters between GFP 
and MBP was analyzed using Image-Pro Plus 6.0.
MRI
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In-vivo MRI was performed on a horizontal 11.7 Tesla MR scanner (Bruker Biospin) with a 
triple-axis gradient (maximum gradient strength=74 Gauss/cm). During imaging, mice were 
anesthetized with isoflurane (1%) in room air and oxygen mixed at 3:1 ratio via a vaporizer, 
and positioned in an animal holder containing circulating warm water (Bruker Biospin). 
Respiration was monitored via a pressure sensor (SAII, Stony Brook) and maintained at 40-60 
breath/min. After imaging, animals recovered within 5 min.
Image acquisition was performed using a quadrature transmit volume coil (70-mm diameter) 
and a 4-channel mouse brain receive-only phased array coil (Bruker Biospin). Multi-slice T2-
weighted images were acquired using the rapid acquisition with refocused echoes (RARE) 
sequence with an echo time (TE) of 50 ms, a repetition time (TR) of 3600 ms, four signal 
averages, echo train length of eight, field of view (FOV) of 15x15 mm, 32 slices, and a native 
resolution of 0.078x0.078x0.50 mm.
Erichrome cyanin staining
Slides were oven-dried at 50°C for 3 h, hydrated in 95% and 70% ethanol. After rinsing with 
distilled water twice, the sections were stained with an erichrome cyanine solution consisting 
of 0.4% FeCl3, 0.2% erichrome cyanine (Sigma-Aldrich) and 0.5% H2SO4. Section 
development was performed by alternating exposure to 0.1% NH4OH for 3-7 s and rinsing in 
distilled water for 30 s until the blue background was reduced and cells turned faintly pink but 
still had blue shading. After the last rinse in water, sections were dehydrated in 70%, 95%, and 
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100% ethanol (two changes), and three changes of xylene for 10 min each before being 
processed for microscopy.
Transmission electron microscopy and g-ratio measurement
Perfused shiverer mouse brains were placed under a fluorescent dissection microscope. A 3-
mm diameter cube was dissected from the mGRP transplanted corpus callosum and fixed in 4% 
glutaraldehyde following postfixation in OsO4, and embedded in Epon. Thin sections of 70 nm 
were stained with citrate/uranyl acetate as recently described (Lyczek et al., 2017). Images were 
acquired using a Zeiss Libra transmission electron microscope from the upper left field and 
then, in a “zigzag” fashion with equidistant movement. G-ratio was measured as inner/outer 
diameter of the myelin sheath (300 axons per animal).
MiRNA in situ hybridization
In situ hybridization (ISH) for miR-223 and miR-146 (miRCURY LNA miRNA probes, 
Exiqon) was performed using miRCURY LNA microRNA ISH Kit (Exiqon) according to 
manufacturer’s protocol. In brief, cryosections were air dried at room temperature and treated 
with Proteinase-K for 10 min, washed twice in PBS. Hybridization mix was then applied for 60 
min at 52°C following washes in descending concentrations of SSC buffers. Next, sections were 
incubated sequentially in blocking solution for 15 min and anti-DIG reagent conjugated with 
rhodamine (Roche) for 60 min. After three washes with PBS and counterstained with DAPI, 
slides were mounted with Floro-Gel Mounting Media (EMS) and imaged with ZEISS AX10 
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fluorescence microscope.
Supplementary Figures and Figure legends
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Supplementary Fig. 1. Spinal cord-derived mGRPs express macroglial lineage but not 
neuronal markers. PLP-GFP positive mGRP cells were isolated from E13.5 mouse spinal cord 
and cultured in selection medium for 10 days. Immunocytochemistry was performed against 
multiple marker antigens indicated at the upper right corners of each images. Scale bar: 50 µm.
Supplementary Fig. 2. Immunocytochemistry for migration-mediating molecules. PLP-
GFP positive mGRP cells were isolated from E13.5 mouse spinal cord and cultured in selection 
medium for 10 days. Immunocytochemistry was performed with (A) CXCR4 and (B) FGFR 
antibodies. Scale bar: 50 µm.
Supplementary Fig. 3. Additional CTLA4-Ig application does not further enhance graft 
survival. Logarithmic BLI values of non-booster group (MR-1 and CTLA4-Ig treatment on 
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POD0, 2, 4, 6, n=5), booster group (additional CTLA4-Ig application on POD30, 60, 90, n=5), 
and control group of B6 mice (n=5) that received intracerebral mGRP transplantation. There 
was no statistical difference between booster and non-booster group at any time point examined. 
Both booster (*, p<0.05) and non-booster group BLI signals (#, p<0.05) were significantly 
higher than in the control group from POD14 onwards. Regression analysis was reported as 
type III tests of fixed effects, with the lowest mean square (LMS) difference test used for 
comparison between means (PROC MIXED, SAS 9.2). A coefficient of determination was 
calculated, and the BLI data were subjected to logistic transformation to maximize the model 
fit.
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Supplementary Fig. 4. Costimulation blockade protects xenogeneic GRPs from immune 
rejection. (A) Intracerebral hGRP engrafted B6 mice were subjected to longitudinal BLI and 
the logarithmic total flux over their heads were plotted. The statistically significant difference 
between CoB and control group (*, p<0.05, n=5) started from POD9 and lasted till POD19. 
There were no BLI signal differences between CoB and scid groups (p>0.4, n=5). Regression 
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analysis was reported as type III tests of fixed effects, with the lowest mean square (LMS) 
difference test used for comparison between means (PROC MIXED, SAS 9.2). A coefficient 
of determination was calculated, and the BLI data were subjected to logistic transformation to 
maximize the model fit. (B) Immunohistochemistry on B6 and scid mouse brain specimens was 
performed with STEM121 antibodies and DAPI staining on POD19. Scale bar: 100/10 µm in 
low/high magnificent images.
Supplementary Fig. 5. GRPs are vital after 19 days of intracerebral transplantation with 
costimulation blockade treatment. Confocal microscopy for PLP-GFP positive mGRPs being 
transplanted into CoB, scid and control mouse brains on POD19. Cell nuclei were stained with 
DAPI. Note that mGRPs extended complex processes in CoB and scid brains indicating the 
integration into host brains, but displayed moribund morphology in control brains. Scale bar: 
10 µm.
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Supplementary Fig. 6. Peripheral Treg population is decreased in costimulation blockade 
treated mice. T cells isolated from naïve, control and CoB B6 mouse spleens were analyzed 
for the proportion (A) and absolute number (B) of CD4+, FoxP3+ Tregs by flow cytometry. 
Control mice had significantly more Tregs residing in the spleen than CoB mice on both POD5 
(p<0.0001) and POD12 (p=0.0016). There was no difference in neither CD4+ cell proportion 
(C) nor absolute numbers (D). Independent two sample t-test (SPSS 22.0).
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Supplementary Fig. 7. Costimulation blockade mitigates the post-transplantation pro-
inflammation cytokine profile. Sera from intracerebrally mGRP transplanted CoB, control, 
and scid mice were drawn on POD5, 11, 17, 25 and subjected to a high throughput cytokine 
analysis. Cytokines that were within the detection range are presented with absolute values and 
standard deviation at different time points examined. One-way ANOVA with LSD post hoc 
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corrections. *p<0.05 between CoB and control mice, &p<0.05 between CoB and scid mice, 
#p<0.05 between scid and control mice (n=5 in each group). 
Supplementary Fig. 8. Clustered heatmaps of the serum cytokines after intracerebral 
mGRP transplantation. Sera from intracerebral mGRP transplanted CoB, control, and scid 
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mice were drawn on POD5, 11, 17, 25 and subjected to a high throughput cytokine analysis. 
Cluster analysis was performed with NCSS Statistical Software based on the quantitative data 
presented in Supplementary Fig. 7.
Supplementary Fig. 9. Costimulation blockade upregulates intragraft miR-146 expression 
post mGRP transplantation. In situ miRNA hybridization with DAPI counterstaining was 
performed for mGRP transplanted CoB and control mouse brains on POD19. (A) Mouse brain 
cryosections were hybridized with miR-146 probes and note its increased expression co-
localizing with mGRPs in CoB brains. Control brains were negative for miR-146 hybridization. 
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(B). Mouse brain cryosections were hybridized with miR-223 probes. There was no positive 
hybridization in neither CoB nor control brains. Scale bar: 50 µm.
Supplementary Table 1. GFP-MBP co-localization parameters.
Manders’ overlap 
coefficient, R
colocalization 
coefficient, m1
colocalization 
coefficient, m2
shiverer-CoB 33d 0.5316±0.1325 0.5793±0.2078 0.9448±0.0468
shiverer-CoB 90d 0.4335±0.1880 0.7489±0.1291 0.8629±0.0917
shiverer-rag2 90d 0.4352±0.1081 0.5355±0.2279 0.8749±0.0929
References:
Lyczek A, Arnold A, Zhang J, Campanelli JT, Janowski M, Bulte JW, et al. Transplanted 
human glial-restricted progenitors can rescue the survival of dysmyelinated mice independent 
of the production of mature, compact myelin. Exp Neurol 2017; 291: 74-86.
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